These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11045159)

  • 21. Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.
    Radin AI; Kim HT; Grant BW; Bennett JM; Kirkwood JM; Stewart JA; Hahn RG; Dutcher JP; Wiernik PH; Oken MM;
    Cancer; 2003 Jul; 98(1):100-9. PubMed ID: 12833462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
    Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
    J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune aspects of cytokine and anticytokine therapies.
    Krause I; Valesini G; Scrivo R; Shoenfeld Y
    Am J Med; 2003 Oct; 115(5):390-7. PubMed ID: 14553875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report.
    Tunca A; Erbayrak M; Aytaç S; Türkay C
    Turk J Gastroenterol; 2004 Jun; 15(2):97-9. PubMed ID: 15334319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon alpha-associated retinopathy in patients with chronic hepatitis C].
    Schmidt S; Pleyer U
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):915-8. PubMed ID: 16308826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.
    Masci P; Olencki T; Wood L; Rybicki L; Jacobs B; Williams B; Faber P; Bukowski R; Tong K; Borden EC
    Clin Pharmacol Ther; 2007 Mar; 81(3):354-61. PubMed ID: 17339865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcoidosis caused by interferon therapy.
    Celik G; Sen E; Ulger AF; Kumbasar OO; Bozkaya H; Alper D; Karayalcin S
    Respirology; 2005 Sep; 10(4):535-40. PubMed ID: 16135181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review.
    Martinelli P; Martinelli V; Agangi A; Maruotti GM; Paladini D; Ciancia R; Rotoli B
    Am J Obstet Gynecol; 2004 Dec; 191(6):2016-20. PubMed ID: 15592285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interferon alpha and autoimmunity].
    Papo T; Piette JC; Du LT; Godeau P
    Ann Med Interne (Paris); 1993; 144(5):357-66. PubMed ID: 8291852
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
    Tanvetyanon T; Choudhury AM
    Ann Pharmacother; 2004 Mar; 38(3):418-21. PubMed ID: 14970365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.
    Nissen MJ; Fontanges E; Allam Y; Zoulim F; Trépo C; Miossec P
    Rheumatology (Oxford); 2005 Aug; 44(8):1016-20. PubMed ID: 15855185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon alfa and autoimmunity.
    Stricker RB
    South Med J; 1996 Jun; 89(6):645. PubMed ID: 8638214
    [No Abstract]   [Full Text] [Related]  

  • 38. Childbearing age patients with essential thrombocythemia: should they be placed on interferon?
    Díez-Martín JL; Banãs MH; Fernández MN
    Am J Hematol; 1996 Aug; 52(4):331-2. PubMed ID: 8701962
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoimmunity and antibodies to interferons in patients with carcinoid tumors--clinical consequences.
    Oberg KE
    J Interferon Res; 1994 Aug; 14(4):215-6. PubMed ID: 7822879
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-alpha induced 'tertiary mania'.
    Kingsley D
    Hosp Med; 1999 May; 60(5):381-2. PubMed ID: 10396419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.